XML 37 R4.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Operating expenses:    
Research and development $ 118,870 $ 120,735
General and administrative 52,332 49,083
Total operating expenses 171,202 169,818
Loss from operations (171,202) (169,818)
Total other income (loss), net:    
Interest income 1,876 1,315
Other income (loss), net 351 (2,452)
Loss before income taxes (168,975) (170,955)
Income tax (benefit) expense (265) 1,007
Net loss $ (168,710) $ (171,962)
Net loss per share - basic $ (2.20) $ (2.74)
Net loss per share - diluted $ (2.20) $ (2.74)
Weighted-average common shares outstanding - basic 76,654,856 62,782,126
Weighted-average common shares outstanding - diluted 76,654,856 62,782,126
Comprehensive loss:    
Net loss $ (168,710) $ (171,962)
Other comprehensive income (loss), net of tax:    
Unrealized (loss) gain on available-for-sale securities (313) 1
Foreign currency translation adjustment   (44)
Total other comprehensive loss (313) (43)
Comprehensive loss $ (169,023) $ (172,005)